Lashondra Garcia

Lashondra Garcia serves as a key procurement professional within the W40M USA HCA under the Department of the Army, responsible for managing acquisitions that sustain medical readiness across battlefield and garrison healthcare environments. She oversees the procurement of critical medical technologies, including surgical instrumentation, diagnostic equipment, and laboratory systems essential to combat medics and military medical facilities. Her role is central to fulfilling the agency’s mission of ensuring operational health through timely, compliant, and technically sound contracting actions that align with DoD healthcare standards and readiness requirements. Garcia maintains consistent relationships with leading medical technology vendors including QUIDELORTHO SALES COMPANY, LLC, STERIS CORPORATION, MDM TECHNOLOGIES, LLC, SYSMEX AMERICA, INC, and LBT DIAGNOSTIC RADIATION PHYSICS CONSULTING LTD. These partnerships reflect a focus on high-reliability medical devices, sterilization systems, diagnostic analyzers, and radiation safety services. Her contracting patterns indicate a preference for established industry leaders with proven compliance, validation, and service support capabilities, particularly in areas requiring FDA-cleared or CE-marked medical equipment. A strong commitment to small business participation is evident in her contracting patterns, with 66.7% of awards structured as Total Small Business Set-Asides under FAR 19.5. This reflects a deliberate strategy to prioritize small business vendors capable of delivering specialized medical equipment and technical services, aligning with federal socioeconomic goals while maintaining mission-critical performance standards. Her procurement portfolio is exclusively categorized under NAICS 532490—Other Commercial and Industrial Machinery and Equipment Rental and Leasing—indicating a specialized focus on leasing and long-term access models for high-value medical instrumentation. This approach enables the agency to maintain cutting-edge diagnostic and surgical capabilities without full ownership, optimizing lifecycle management and fiscal flexibility while ensuring continuous operational readiness.